700 patients110,866 observations180 daysLIVE

Patient P-02291

Synthetic patientMETA-24 · Day 179 · 75+ · M · baseline S15Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Deteriorating
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
15%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S15
  2. Day 121 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 121.

Primary contributors, last 14 days
  • GI instability-18
  • Inflammatory activity-11
  • Toxicity+8
  • Nutritional resilience+5

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    45 min
    improving · +5.9 vs previous 14 d
    Sleep duration
    Wearable
    6.9 h
    stable · +0.2 vs previous 14 d
    Energy level
    Daily log
    5.6/10
    improving · +0.4 vs previous 14 d
    Steps
    Wearable
    4,715
    improving · +501 vs previous 14 d
    GI burden
    Companion
    13.4/100
    improving · -9.6 vs previous 14 d
    Adherence
    Companion
    82.4 %
    stable · -2.8 vs previous 14 d
    Sleep quality
    Wearable
    50.5/100
    improving · +6.0 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    134 mg/dL
    stable · -1.1 vs previous 14 d
    This trajectory is decaying — what would help, what would not
    Steering view →

    Heading towards restoration · 73 from the failing basin, 48 from restoration.

    Would help
    • No untried action with strong evidence. Compose one from primitives.
    • More protein
      GI -4.5 next day on high-intake days · n 25
    Would not help
    • BR-03 Behavioural Recommendation
      only 30% improved among 10 similar
    • Keep histamine low
      GI +5.4 next day on high-intake days · n 12
    • Keep alcohol low
      GI +5 next day on high-intake days · n 17
    • Keep ultra-processed low
      GI +4.1 next day on high-intake days · n 17
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Histamine load
      +5.4detractor · 95%
    • Alcohol
      +5detractor · 95%
    • Protein
      -4.5supporter · 95%
    • Ultra-processed food
      +4.1detractor · 95%
    • Insoluble fibre
      -0.9no signal · 21%
    • Caffeine
      +0.8no signal · 19%
    • Dietary fat load
      +0.4no signal · 15%
    • Simple carbohydrates
      0no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Mucosal barrier integrity 30
      • DNAFUT2 non-secretor lowers mucosal fucosylation
    • Inflammatory signalling 25
      • DNAIL6 -174 variant raises baseline inflammatory tone
    • Autonomic recovery 25
      • WearableResting HR 74 bpm
    DNA
    Fictional pharmacogenomic panel
    • FUT2 rs601338 AA (non-secretor)
      Reduced mucosal fucosylation
    • IL6 -174 G/C
      Higher inflammatory tone
    • CYP2D6 Intermediate metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 4 · butyrate capacity 50/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisNormal
    • Bifidobacterium longumLow
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    51 ms
    Sleep
    6.6 h
    Steps
    5,669
    Resting HR
    73 bpm
    Daily log: GI score 13, nutritional resilience 65, adherence 82.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Keep fibre steady; no new sources this week
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Log the daily check-in; one line is enough
    • A 15-minute walk after lunch
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0252246%S01BR-03no change40
    P-0208741%S01BR-03no change40
    P-0237540%S0144
    P-0204139%S0127
    P-0226938%S0127
    P-0243836%S0132
    P-0256833%S0151
    P-0263831%S01BR-03improved41
    P-0266231%S0120
    P-0268131%S0151
    P-0230730%S0155
    P-0221729%S0161